当前位置:首页 - 行情中心 - 华北制药(600812) - 财务分析

华北制药

(600812)

  

流通市值:89.90亿  总市值:89.90亿
流通股本:17.16亿   总股本:17.16亿

华北制药(600812)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润0.49亿元,每股收益0.02元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益693389.17万元,未分配利润-36913.36万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产2145201.09万元,负债1451811.91万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入2,153,167,876.499,241,652,953.87,484,828,636.645,275,037,790.2
营业总成本2,088,645,071.898,957,348,085.027,258,017,573.935,064,452,841.41
其他经营收益
营业利润66,574,787.5353,971,603.38286,904,212.36213,773,689.18
利润总额66,281,203.77357,408,948.04287,215,555.62214,036,244.45
净利润49,376,883.19257,453,101.84211,538,869.17162,286,856.6
每股收益
其他综合收益-1,662,299.38-14,247,723.02-209,831.87-412,469.02
综合收益总额47,714,583.81243,205,378.82211,329,037.3161,874,387.58
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计8,265,350,407.228,131,296,097.388,336,620,392.118,564,390,541.75
非流动资产:
非流动资产合计13,186,660,450.8813,260,607,289.5813,200,664,532.4513,188,551,499.17
资产总计21,452,010,858.121,391,903,386.9621,537,284,924.5621,752,942,040.92
流动负债:
流动负债合计11,436,666,528.9612,399,264,384.6912,409,673,422.3812,108,718,070.56
非流动负债:
非流动负债合计3,081,452,5962,107,642,023.682,453,582,912.282,919,971,517.19
负债合计14,518,119,124.9614,506,906,408.3714,863,256,334.6615,028,689,587.75
所有者权益(或股东权益):
归属于母公司股东权益合计5,549,821,971.615,514,831,272.765,505,224,974.655,467,083,266.95
股东权益合计6,933,891,733.146,884,996,978.596,674,028,589.96,724,252,453.17
负债和股东权益合计21,452,010,858.121,391,903,386.9621,537,284,924.5621,752,942,040.92
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计1,501,402,325.397,839,785,548.215,641,276,009.823,545,924,571.69
经营活动现金流出小计1,342,736,168.986,663,246,292.214,979,830,131.483,054,426,514.78
经营活动产生的现金流量净额158,666,156.411,176,539,256661,445,878.34491,498,056.91
投资活动产生的现金流量:
投资活动现金流入小计40,20061,083,992.3660,596,232.860,008,200
投资活动现金流出小计122,790,203.99842,012,200.76680,002,187.69235,625,353.31
投资活动产生的现金流量净额-122,750,003.99-780,928,208.4-619,405,954.89-175,617,153.31
筹资活动产生的现金流量:
筹资活动现金流入小计3,983,598,00010,812,750,0007,060,360,0004,517,450,000
筹资活动现金流出小计4,320,586,932.7611,198,014,329.977,193,011,402.25,031,506,160.34
筹资活动产生的现金流量净额-336,988,932.76-385,264,329.97-132,651,402.2-514,056,160.34
汇率变动对现金及现金等价物的影响-5,914,930.01477,331.533,040,427.583,877,130.09
现金及现金等价物净增加额-306,987,710.3510,824,049.16-87,571,051.17-194,298,126.65
期末现金及现金等价物余额966,240,291.831,273,228,002.181,174,832,901.851,068,105,826.37
补充资料:
现金及现金等价物的净增加额-10,824,049.16--194,298,126.65
TOP↑